Dr. Edward Kavalerchik graduated the medical school from the Stony Brook University School of Medicine and soon after that he completed both his residency and fellowship program at the University of California San Diego. He is specialized in oncology and board certified in medical oncology. Dr. Kavalerchik has been in practice for more than 11 years and is affiliated with the La Jolla Office. During his career, he has also contributed to five publications of medical interest.
Dr. Edward Kavalerchik has contributed to 3 publications.
Serum free light chain reduction correlates with response and progression-free survival following carfilzomib therapy in relapsed/refractory multiple myeloma.
Vij R, Wang M, Jagannath S, Niesvizky R, Jakubowiak AJ, Kavalerchik E, Huang M, Siegel DS; Leuk Lymphoma. 2015.
Dr. Edward Kavalerchik graduated the medical school from the Stony Brook University School of Medicine and soon after that he completed both his residency and fellowship program at the University of California San Diego. He is specialized in oncology and board certified in medical oncology. Dr. Kavalerchik has been in practice for more than 11 years and is affiliated with the La Jolla Office. During his career, he has also contributed to five publications of medical interest.
Dr. Edward Kavalerchik has contributed to 3 publications.
Serum free light chain reduction correlates with response and progression-free survival following carfilzomib therapy in relapsed/refractory multiple myeloma.
Vij R, Wang M, Jagannath S, Niesvizky R, Jakubowiak AJ, Kavalerchik E, Huang M, Siegel DS; Leuk Lymphoma. 2015.
Hospitals & Clinics
specialties & services
